Department of Surgery and Transplantation, Zurich University Hospital, Zurich, Switzerland.
Department of Surgery, Geneva University Hospital, Geneva, Switzerland.
Transpl Int. 2019 May;32(5):459-469. doi: 10.1111/tri.13430. Epub 2019 Apr 5.
The lack of suitable kidney donor organs has led to rising numbers of patients with end stage renal disease waiting for kidney transplantation. Despite decades of clinical experience and research, no evaluation process that can reliably predict the outcome of an organ has yet been established. This review is an overview of current methods and emerging techniques in the field of donor kidney evaluation prior to transplantation. Established techniques like histological evaluation, clinical scores, and machine perfusion systems offer relatively reliable predictions of delayed graft function but are unable to consistently predict graft survival. Emerging techniques including molecular biomarkers, new imaging technologies, and normothermic machine perfusion offer innovative approaches toward a more global evaluation of an organ with better outcome prediction and possibly even identification of targets for therapeutic interventions prior to transplantation. These techniques should be studied in randomized controlled trials to determine whether they can be safely used in routine clinical practice to ultimately reduce the discard rate and improve graft outcomes.
缺乏合适的肾脏供体器官导致越来越多的终末期肾病患者等待肾移植。尽管有几十年的临床经验和研究,但尚未建立能够可靠预测器官结局的评估方法。本文综述了移植前供体肾脏评估领域当前的方法和新兴技术。组织学评估、临床评分和机器灌注系统等既定技术可以相对可靠地预测移植物功能延迟,但无法一致预测移植物存活率。新兴技术包括分子生物标志物、新型成像技术和常温机器灌注,为更全面地评估器官提供了创新方法,可更好地预测结局,甚至有可能在移植前确定治疗干预的靶点。这些技术应在随机对照试验中进行研究,以确定它们是否可以安全地用于常规临床实践,从而最终降低器官废弃率并改善移植物结局。